Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yueyang Wang, Ph.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yueyang Wang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yueyang Wang has written about over time.
Animals, 1 publications between 2019 and 2019, average publication date May 2019. Antibiotics, Antineoplastic, 1 publications between 2019 and 2019, average publication date May 2019. Apoptosis, 1 publications between 2019 and 2019, average publication date May 2019. Fatty Acids, 1 publications between 2019 and 2019, average publication date May 2019. Humans, 1 publications between 2019 and 2019, average publication date May 2019. Hypoxia-Inducible Factor 1, alpha Subunit, 1 publications between 2019 and 2019, average publication date May 2019. Lactones, 1 publications between 2019 and 2019, average publication date May 2019. Mice, Inbred BALB C, 1 publications between 2019 and 2019, average publication date May 2019. Mice, Nude, 1 publications between 2019 and 2019, average publication date May 2019. Neoplasms, 1 publications between 2019 and 2019, average publication date May 2019. Neoplastic Processes, 1 publications between 2019 and 2019, average publication date May 2019. Signal Transduction, 1 publications between 2019 and 2019, average publication date May 2019. Streptomyces, 1 publications between 2019 and 2019, average publication date May 2019. TOR Serine-Threonine Kinases, 1 publications between 2019 and 2019, average publication date May 2019.

To see the data from this visualization as text, click here.
Wang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.